The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer
暂无分享,去创建一个
D. von Laer | B. Stierstorfer | C. Urbiola | G. Wollmann | P. Müller | J. Kimpel | K. Das | M. Petersson | L. Schreiber | P. Erlmann | Fabian Heinemann | B. Spiesschaert